Immunotherapy clinical trial gave kidney cancer patient hope
Rick Frantz was diagnosed with stage IV kidney cancer in early 2016. A CT scan at MD Anderson Cancer Center revealed a large tumor on his left kidney and smaller tumors in both lungs, liver, chest area and several areas in the bone.
Rick didn't have many treatment options. Dr. Matthew Campbell told Rick his most promising option might be to qualify for an immunotherapy clinical trial. Rick agreed, and after qualifying for the trial, he started receiving infusions of the immunotherapy drugs Nivolumab and Bevacizumab.
After just one treatment, Rick began to feel much better. After three, he was back on his feet and almost feeling back to normal. Watch Rick describe his experience and feelings with immunotherapy.
Read Rick's story https://www.mdanderson.org/pub....lications/cancerwise
Request an appointment at MD Anderson by calling 1-877-632-6789 or online at: https://my.mdanderson.org/Requ....estAppointment?cmpid
-
Category
No comments found